Posts by Sandra Ansanay-Alex
Aktiia closes a CHF 34 million Series B and becomes Hilo
Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by Earlybird Health and Wellington Partners, with new investors Kfund and naturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures. The investment, which has brought the total financing to…
Read MoreGESICA: Strengthening Cross-Border Health Crises Readiness
In an era marked by mounting pressure on healthcare systems and a growing number of exceptional public health emergencies, cross-border scientific collaboration has never been more critical. The GESICA project—GEstion des SItuations de Crises sAnitaires—is designed to address this challenge by enhancing the ability to detect, anticipate, and manage health crises across the France–Switzerland region.…
Read MoreBioscibex, Inkocell Therapeutics, and OrthoSens Supported By Venture Kick
Bioscibex, Inkocell Therapeutics, and OrthoSens were selected at Venture Kick’s second financial and entrepreneurial support stage and get each a CHF 40’000 support. These three Swiss Health Valley startups reshape biopharma, oncology, and orthopedic recovery. Bioscibex, Inkocell Therapeutics, and OrthoSens have progressed to the second stage of Venture Kick, securing support to drive their innovations…
Read MoreAerospec, Carewell, OptiZone and SaisiR Finalists of the PERL Prize
Four Swiss Health Valley start-ups selected from the 5 finalists in the 23rd Prix Entreprendre Lausanne Région (PERL): Aerospec, Carewell, OptiZone and SaisiR. Nearly 60 companies from the Lausanne region applied for the PERL 2025 awards. Only five have been selected for the Awards Ceremony, to be held on Wednesday 7 May, and only one…
Read MoreYour research at Lonza
Submit your research project before 30 June 2025 and get a session at Lonza’s High Throughput Experimentation (HTE) lab Push the boundaries of your research with a unique opportunity to collaborate with Lonza’s state-of-the-art High Throughput Experimentation (HTE) lab in Visp, Switzerland. Submit your research idea and stand a chance to win a fully…
Read MoreHealium, Hikane and LittleCubes Supported By FIT
These three new life sciences projects have each been awarded a FIT Impact grant of 10,000 CHF. Healium is developing Medicase, a compact and connected pill-dispenser designed to improve adherence to treatment. Designed for the visually impaired, Hikane is a compact device that attaches to any white cane and provides haptic feedback to signal the…
Read MoreLondon Biotechnology Show
The London Biotechnology Show is taking place on 18-19 June 2025 in ExCel London The London Biotechnology Show is a premier event taking place in the United Kingdom to expedite the progress of biotechnology for revolutionising the medical & healthcare sectors in the region and across the globe. +3500 business attendees + 1800 biotech…
Read MoreISREC- SCCL Symposium
The ISREC- SCCL Symposium 2025 is taking place on 1- 4 September 2025 in Lausanne, Switzerland Four days of outstanding presentations on the latest findings from the cancer research community, where scientists, clinicians and researchers gather to share the latest advances in cancer science and medicine. From cancer biology, translational, and clinical studies; to…
Read MoreSiemens Life Sciences Week
Life Science Week is taking place for the second time at Siemens in Zug from 24 to 27 June 2026 Strengthening the competitiveness of the Swiss life sciences industry through digital solutions! Studies show that digitisation could boost the competitiveness of the Swiss life sciences industry by up to 20% over the next…
Read MoreHeroSupport Partners With Swiss Medical Network
HeroSupport, a HUG spin-off founded in 2022 by medical physicist Giovanna Dipasquale, is redefining breast cancer treatment with its 3D-printed, custom-made shells designed to improve the precision and comfort of radiotherapy. The Geneva-based startup has just announced a strategic partnership with Swiss Medical Network, a major milestone in its mission to enhance cancer care. …
Read More